It has recently been proposed that in rat models of genetic hypertension, supplemental dietary potassium preserves release of endothelium-derived relaxing factor independently of its capacity to either attenuate hypertension or increase plasma potassium. To test this hypothesis in Dahl salt-sensitive rats given sodium chloride (4%) for 3 weeks, we supplemented dietary potassium (2.1%) with either KCI (n=16) or KHCO 3 (n=16). Compared with unsupplemented rats (n=16), rats supplemented with either potassium salt had a lower mean arterial pressure and a greater release of endothelium-derived relaxing factor, as assessed from acetylcholine-induced relaxation of precontracted aortic rings. However, the maximum relaxation response to acetylcholine correlated inversely with blood pressure (r=-.82, P<.001), not only in the KCI (r=-.68, J><.002) and KHCO 3 (r=-.77, P<Ml) groups but also in unsupplemented rats (r=-.86, P<.001). With potassium supplementation, plasma potassium concentrations measured between 4 and 6 PM did not increase, but those measured between 4 and 6 AM did increase (P<.05). In isolated ring segments, aortic compliance was greater in both the KCI and KHCO 3 groups than in unsupplemented rats (0.015 and 0.017 vs 0.009 mm 2 /mm Hg) (P<.01). This greater compliance could not be related to differences in blood pressure, plasma potassium, or collagen or elastin content of the aortic wall. In salt-loaded Dahl salt-sensitive rats in which supplemental dietary potassium attenuates hypertension, (1) the extent to which release of endothelium-derived relaxing factor is preserved is directly related to the extent to which potassium restricts the salt-induced rise in blood pressure, (2) nocturnal but not diurnal plasma potassium is increased, and (3) aortic compliance is enhanced. (Hypertension. 1993;22:315-322.) 
B
y modulating the contractile state of vascular smooth muscle subjacent to the site of its release, endothelium-derived relaxing factor (EDRF) is a major physiological determinant of vascular tone, 1 regional blood flow, 2 and systemic arterial blood pressure. 3 The extent to which EDRF release can be induced is a measure of endothelial function and can be indirectly assessed in vitro from the extent to which acetylcholine induces vasodilation in aortic rings precontracted with norepinephrine. 45 In recently published studies using this technique for this assessment, 4 -5 supplemental dietary potassium is reported to preserve the release of arterial EDRF in the salt-loaded, hypertensive Dahl salt-sensitive (DS) rat 4 and in the salt-loaded, hypertensive stroke-prone spontaneously hypertensive rat (SHRSP). 5 Because either pharmacological or surgical attenuation of hypertension can preserve or restore arterial EDRF release, 68 supplemental dietary K + might preserve EDRF release by its antihypertensive effect alone. 9 
"
13 But in the studies of both the DS rat and SHRSP, 45 it is contended that supplementation of dietary K + preserved EDRF release without attenuating hypertension and hence that this capacity of potassium is independent of its antihypertensive effect.
Yet in the study of the SHRSP under consideration, 5 attenuation of hypertension throughout the initial 4-week period of K + supplementation 14 might account for the preserved release of EDRF observed 4 weeks afterward, 5 even though at that time, hypertension was found to be not attenuated. And in the study of the DS rat, supplemental dietary K + that preserved EDRF release did in fact also attenuate hypertension, except when the mean blood pressure of the K + -supplemented rats was compared with that of a small subgroup of unsupplemented rats selected post hoc for the lowest values of blood pressure. 4 Furthermore, in this subset, mean EDRF release was greater than that measured in the unsupplemented group as a whole. Accordingly, supplemental dietary potassium might preserve EDRF release only to the extent that it restricts the rise in blood pressure induced by salt loading. We report a positive test of this hypothesis in the current study of a large group of salt-loaded DS rats in which supplemental dietary K + predictably attenuated hypertension.
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In the aforementioned studies of SHRSP and DS rats, 4 ' 5 it is also contended that supplementation of dietary K + preserved EDRF release without increasing the plasma concentration of potassium. Indeed, in both models of hypertension, it might appear that dietary supplementation of potassium attenuates hypertension without inducing an increase in the plasma concentration of K + . 4 -515 Because rats feed mainly at night, supplementing dietary K + might increase the nocturnal but not diurnal plasma concentration of potassium. We report a positive test of this hypothesis.
In many studies, dietary K + supplementation has been shown to reduce systolic blood pressure more than diastolic blood pressure. 1619 Systolic hypertension can be caused by reduced arterial compliance. 20 Antihypertensive agents such as nitrovasodilators 21 and converting enzyme inhibitors 22 that mainly lower systolic blood pressure are said to do so by exerting a relaxing effect on arterial smooth muscle that increases arterial compliance. 23 In the current study, we determined whether supplemental K + preserved aortic compliance and whether the demonstrated preservation could be related to attenuation of hypertension. Finally, because the chloride ion may exert vasoconstrictive effects of its own 24 -25 and the chloride moiety of potassium chloride might constrain the antihypertensive effect of potassium, we examined the effects of supplementation with both potassium chloride (KG) and potassium bicarbonate (KHCO 3 ) on blood pressure and vascular function.
Methods

Animals and Diet
Four-to 5-week-old inbred male DS rats (SS/Jr strain) were obtained from Harlan Sprague Dawley Inc, Indianapolis, Ind, and individually housed in metabolic cages.
All rats were fed a high sodium chloride (NaCl) diet prepared by supplementing Purina Rat Chow with 40 g/kg NaCl (the basal NaCl content of the chow before addition of supplemental NaCl was 0.58%; the basal potassium content was 1.1%). Experimental animals were fed the high NaCl diet supplemented with 2.1% potassium provided in the form of either KC1 or KHCO 3 . Control animals were fed the high NaCl diet without supplemental potassium. A pair-feeding protocol was followed to ensure that the daily food intake for each group was nearly identical. Distilled water was provided ad libitum. All studies were conducted in accordance with the guidelines of the Committee on Animal Research, University of California, San Francisco.
Blood Pressure Measurements
After 3 weeks of rats on either the control or experimental diet, the mean arterial pressure (MAP) of each rat was measured in the unanesthetized, unrestrained state through indwelling femoral artery catheters. Each rat was briefly anesthetized with methoxyflurane, and a catheter (PE 50) was implanted in the femoral artery, the distal end being tunneled subcutaneously to an exit at the nape of the neck. The catheter was filled with a heparinized solution of 5% dextrose and plugged with a stainless-steel obturator. After surgery, each rat was returned to its cage to recover from anesthesia; blood pressures were measured 3 days after the anesthetic agent was stopped at a time (1 to 4 PM) when the animals were fully alert and roaming freely within their cages.
For measurement of blood pressure, the femoral catheter was connected via an extension catheter (PE 50) to a low-volume pressure transducer (model P50, Gould Inc, Cleveland, Ohio). The measurement of blood pressure was begun 30 to 60 minutes after the catheter was connected to the transducer. The output of the transducer was routed to a Gould preamplifier and the MAP signal passed to an analog-to-digital convertor (DASH-8, Metrabyte Co, Taunton, Mass) installed in an IBM AT microcomputer. Data acquisition software was used to sample the blood pressure signal every 15 seconds over a period of 2 hours. The average of these 480 measurements obtained over 2 hours was then calculated to yield the MAP of each animal.
Measurements of Plasma and Urine Concentrations of Potassium and Other Electrolytes
Heparinized blood samples were obtained after measurement of MAP. The first sample (approximately 1 mL) was collected between 4 and 6 PM. The animals were then returned to their cages and given ad libitum access to their respective diets. A second blood sample was then collected between 4 and 6 AM on the following day. With each sample, the blood was immediately centrifuged and the plasma obtained for subsequent measurement of potassium concentration (flame photometry). Blood pH and bicarbonate were also measured with a blood gas analyzer (Radiometer America Inc, Westlake, Ohio). Urinary sodium and potassium were measured from 24-hour collections (flame photometry), and cumulative excretion over the entire 3-week treatment period was calculated.
Measurements of In Vitro Aortic Endothelium-Derived Relaxing Factor Release and Compliance
Perfusion apparatus and imaging device. Twenty-four to 48 hours after the second blood sample was collected, the rats were killed by decapitation. The descending thoracic aorta was harvested after carefully cauterizing its side branches. A 25-mm segment was suspended in a perfusion apparatus containing physiological salt solution with the following composition (mM) 2 and maintained at 37°C. The vessel was continuously perfused with physiological salt solution from a 1 L capacity reservoir using a pulsatile peristaltic pump (Cole-Parmer Instrument Co, Chicago, 111). Perfusion pressure was monitored continuously from a side arm with a pressure transducer (Statham) connected to a polygraph (Chart, MacLab/4, Analog Digital Instruments, Palo Alto, Calif). Vascular dimensions were measured in vitro using two-dimensional ultrasonic imaging in a manner similar to that previously described. 26 - 27 In brief, an ultrasound transducer (20 MHz) was suspended beside the vessel, and cross-sectional images were generated with a CVIS Insight system (Cardiovascular Imaging Systems, Sunnyvale, Calif). Images were continuously recorded on videotape for subsequent off-line analysis. Selected portions of the videotape were digitized (8 bits, Rasterops 324, Santa Clara, Calif) and stored on a computer disk. An observer who was blinded to which diet the rat received performed mea-surements of cross-sectional area using specialized software developed in our laboratory.
Response to acetylcholine. For pharmacological experiments, a perfusion pressure of 70 mm Hg was selected. Although this was lower than in vivo pressure, previous in vitro studies in vessels of different sizes have shown that the maximum active tension in response to pharmacological agonists was generated at a transmural pressure of approximately 60 to 70 mm Hg. 2830 All vessels were thus studied at identical transmural pressures to minimize the confounding effect of variable perfusion pressures on local EDRF release. Aortic segments were precontracted by perfusion with phenylephrine (1 nM) for 10 minutes. Measuring cross-sectional areas at 1 log M increments in acetylcholine concentrations (0.1 nM to 0.1 mM), we generated cumulative concentration-response curves. The vessel was perfused for 5 minutes at each concentration. In addition, to study endothelium-independent vasodilation, we examined the relaxation response produced by a near-maximal concentration of sodium nitroprusside (0.1 fiM, 10 minutes) in vessels precontracted with phenylephrine (1 /xM, 10 minutes).
Measurement of compliance. Aortic segments were perfused at pressures increasing from 20 to 200 mm Hg in steps of 20 mm Hg. At each pressure, cross-sectional images were recorded for subsequent off-line analysis of cross-sectional areas. Because the volume of a cylinder equals cross-sectional area times length, for a vessel of fixed length, cross-sectional area is directly proportional to volume. In each vessel, the relation of pressure to cross-sectional area was examined to measure vascular compliance.
Histological examination. At the end of each experiment, aortas were fixed in 10% neutral buffered Formalin, embedded in paraffin, and sectioned at 5 /xm thickness. A section from each vessel was then stained with VerhoefFs elastin and Masson's trichrome stain, which stains elastin fibers black and collagen blue. Color micrographs and stage micrometer images were videotaped with a Zeiss microscope equipped with a color CCD camera. As with ultrasound images, selected portions of the videotape were digitized (Rasterops 324) and stored on computer disk. Media thickness was measured with specialized software developed in our laboratory. With the use of computer-assisted colorimetry, the number of black pixels in a high power field, representative of elastin content, was measured and normalized to the total number of pixels in the field to obtain an "elastin index." Similarly, a "collagen index" was quantitated from the number of blue pixels in sections stained with the elastin trichrome stain.
Calculations and Statistical Analysis
For concentration-response curves to acetylcholine, the range of response to phenylephrine was used as a reference (100%), and results were expressed as the percentage of relaxation in response to cumulative dose increments of drug. EC 50 values and E max (maximum relaxation) for each vessel were calculated. In the case of the compliance curves, the slope of the linear part of the pressure-cross-sectional area relation (0 to 180 mm Hg) was calculated for each vessel. Comparisons among the three groups were performed using analysis of variance and a Student-Newman-Keuls test. Corre- lations between blood pressure and plasma concentration of potassium to estimates of EDRF release (ie, maximum response to acetylcholine, E max ) and compliance (slope of the pressure-cross-sectional area relation) were examined using linear regression by the least-squares method. Differences between the regression lines for the relation between blood pressure and EDRF release across the three groups were assessed using the overall test for coincidental regressions. 31 Results are expressed as mean±SEM, and the null hypothesis was rejected at a value of P<.05.
Results
Blood Pressure and Body Weight
MAP was significantly lowered and to the same extent in both groups treated with potassium salts (control, 150±2.6; KCl, 130±1.6, P<.001; KHCO 3 , 134±3.3 mm Hg, i><.005) (Fig 1) . Body weight at 3 weeks was lower in the KCl group but not the KHCO 3 group compared with control, although total food intake was not different (Table) .
Plasma and Urine Potassium and Other Electrolytes
Diurnal K + concentrations were not significantly different from control in the KCl group but were 7% lower in the KHCO 3 group (F<.05, Table) . Nocturnal plasma potassium was significantly higher in the potassiumtreated rats (P<.05) and higher in the KHCO 3 than in the KCl group (P<.05) (Table) . Blood bicarbonate was lower in the KCl-treated group compared with control, but blood pH was not different. Total urinary sodium excretion was 8% lower in the KCl-treated group compared with control but not in the KHCO 3 -treated group, whereas total urinary potassium excretion was 2.4-fold higher in the KCl group and 2.6-fold higher in the KHCO3 group compared with control (see the Table) .
Effect of Potassium on Endothelium-Dependent Relaxations
There was no significant difference among the three groups in the vasoconstrictor response to phenylephrine (1 /xM) as determined by a decrease in cross-sectional area. Maximum relaxation to acetylcholine (E max ) was were made after 3 weeks on experimental diet unless significantly greater in the potassium-treated groups (F=6.87, P=.OO2 by analysis of variance) (Fig 2) . When data from all 48 animals were pooled, there was a strong inverse correlation between the E max in response to acetylcholine and MAP (r=-.82, P<.001) (Fig 3) . This inverse relation of E max to MAP was also seen in each of the individual groups (control, _y=208.04-0.93x, r = -. 8 6 , f<.001; KCI, ^ = 211.6-0.91.*, r = -. 6 -log M). The relaxation response to the endotheliumindependent vasodilator sodium nitroprusside (0.1 juM) was greater than 90% in all three groups (control, 92±4%; KCI, 97±3%; KHCO 3 , 93±5%).
Effect of Potassium on Vascular Compliance
In the compliance experiments, the slope of the pressure-cross-sectional area relation was significantly increased by potassium supplementation but to a similar degree in the KCI and KHCO 3 groups (control, 0.009±0.0005; KCI, 0.015±0.0006, P<.01; KHCO 3 , 0.017±0.0007 mnrVmmHg, /><.01) (Fig 4) . However, the slope of the pressure-cross-sectional area relation did not correlate with either blood pressure or plasma potassium concentrations in either the entire cohort of 48 rats or in each individual group.
Histological Studies
There was no significant difference in media thickness, elastin content, or collagen content of the aortic wall among the three groups. Endothelium was intact and unremarkable in all sections.
Discussion
In the current study of the salt-loaded DS rat, we have confirmed earlier observations that dietary supplementation of potassium attenuates hypertension 91113 and preserves EDRF release 4 ' 5 as measured indirectly from acetylcholine-induced relaxation of precontracted aortic rings. The results of the current study demonstrate that, in this experimental circumstance of potassium supplementation of 3 weeks' duration, the extent to which hypertension is attenuated is directly and significantly related to the extent to which EDRF release is preserved; with supplementation of either KHCO3 or KCl, the regression line defining the inverse relation between blood pressure and EDRF release is highly significant, and the two lines are not different from each other. Given that both surgical and pharmacological attenuation of hypertension predictably preserve EDRF release in a variety of experimental animal models of hypertension, 6 -832 it would be difficult to argue that in the current study attenuation of hypertension by potassium supplementation did not at least contribute to the preservation of EDRF release. With respect to both slope and intercept, the two regression lines defining the relation between blood pressure and EDRF release in the rats supplemented with potassium are not different from that line defining this relation in rats unsupplemented with potassium. Thus, in the current study, the capacity of potassium supplementation to restrict the salt-induced rise in blood pressure fully accounts for its capacity to preserve EDRF release, whatever the mechanism of that restriction.
Preliminary observations have suggested that K + can increase EDRF release from cultured endothelial cells in vitro. 33 It could be argued that in the current study supplemental K + directly enhances EDRF release and thereby restricts an increase in blood pressure, a variable enhancement accounting for the observed inverse relation between blood pressure and EDRF release. Clearly, our studies do not exclude this possibility. But if supplemental K + does induce a variably enhanced release of EDRF, it cannot be related to the observed increases in plasma potassium induced by supplemental potassium in the current study (see below); the extent of preservation of EDRF release is not related to the extent of the observed increase in nocturnal plasma K + . Irrespective of whether the enhancement of EDRF release induced by K + supplementation is either the result or the cause of the observed attenuation of hypertension, the enhancement and attenuation would seem to be causally related.
Raij et al 4 have recently concluded that in the DS rat in which dietary potassium was supplemented for 7 weeks, the capacity of this supplementation to preserve endothelium-dependent relaxation is independent of its capacity to attenuate hypertension. But in the current study of relatively short-term supplementation, had potassium exerted a preserving effect on EDRF release independent of its antihypertensive effect, one might have anticipated some preservation of EDRF release in at least some of the rats in which potassium supplementation failed to attenuate hypertension. But such preservation did not occur. Rather, in each of that minority of five rats in which potassium supplementation failed to restrict blood pressure to a value less than 150 mm Hg (see Fig 3) , the extent of impairment in EDRF release was not different from that in similarly hypertensive rats unsupplemented with potassium. It might be noted that in the study of Raij et al 4 in DS rats, preservation of EDRF release varied inversely with blood pressure, when data from all three salt-loaded study groups are considered. We would conclude that in the salt-loaded DS rat the capacity of supplemental dietary potassium to preserve EDRF release is not independent of its capacity to attenuate hypertension, at least after a 3-week period of such supplementation, when that supplementation clearly restricts the rise in blood pressure.
In previous studies of salt-loaded, salt-sensitive hypertensive rats, 45 including the DS rat, 46 it has been shown that supplemental dietary K + does not affect endothelium-independent vasorelaxation, as judged from complete concentration-response curves to sodium nitroprusside. Similarly, in the current study, the greater maximal response to acetylcholine in ^-s u pplemented rats cannot be explained by an endotheliumindependent mechanism (ie, a heightened range of smooth muscle relaxation), as judged from the maximal vasodilator response to sodium nitroprusside, 34 which was not greater in the K + -supplemented rats and was greater than 90% in all groups. Thus, in the DS rat that is salt loaded for 3 weeks, we would conclude that supplemental dietary K + preserves EDRF release only to the extent that it restricts the rise in blood pressure. Raij et al 4 demonstrated that dietary K + supplementation had no effect on EDRF release in the Dahl salt-resistant (DR) rat and that K + supplementation in the DS rat was attended by a level of EDRF release not different from that observed in DR rats. Thus, although we did not study the DR rat or any other normotensive control, it seems likely that K + supplementation mitigated an otherwise impaired release of EDRF in the salt-loaded DS rat.
In some studies of the effect of K + supplementation on blood pressure 35 and on endothelial function 4 -5 in the DS rat and the SHRSP, it has been reported that plasma concentrations of K + remained unchanged. It is therefore contended that the antihypertensive effect of K + and its preserving effect on the endothelium are independent of changes in plasma K + . 4 -5 But in those studies, plasma concentrations of K + appear not to have been measured at night. 4535 Because rats are mainly nocturnal feeders, one might expect K + supplementation to induce the greatest increase in plasma concentration of K + at night or early morning. In fact, in the present study, the diurnal value of the plasma concentration of potassium did not increase, whereas the nocturnal value increased substantially. The failure of dietary K + to induce a rise in diurnal plasma K + may be unique to the Dahl rat. In at least three studies of K + -supplemented Dahl rats, presumably diurnal values of plasma K + have been reported to be not increased 43536 ; we are unaware of any studies showing a diurnal increase. By contrast, a presumably diurnal increase in the plasma concentration of potassium has been repeatedly shown in the spontaneously hypertensive rat supplemented with potassium.
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In the present study, dietary supplementation of potassium enhanced arterial compliance (compared with unsupplemented rats), an enhancement that could mediate, at least in part, its antihypertensive effect. Many studies have suggested that K + supplementation reduces systolic blood pressure more than diastolic blood pressure.
1619 Agents such as nitrovasodilators 21 - 40 and angiotensin converting enzyme inhibitors 22 that attenuate systolic blood pressure may do so by inducing a relaxing effect on smooth muscle of medium-sized and large arteries that increases their compliance. 23 - 41 Nitrovasodilators induce vasodilation through their metabolism to nitric oxide in vascular smooth muscle. 42 Nitric oxide is an important component of EDRF. 43 -44 Because the present study and those of others 45 have shown that supplemental dietary K + preserves the capacity of aortic rings to release EDRF, the vasodilator mechanism of K + supplementation may be similar to that of nitrovasodilators in large arteries. 23 Indeed, because enhanced aortic compliance induced by supplemental K + could not be related to any obvious structural changes in the aortic media in our study, the enhancement might reflect a decrease in aortic smooth muscle tone caused by supplemental K +4548 mediated in part by EDRF. Relaxed vessels are more compliant than contracted vessels, possibly because vascular smooth muscle is in series with collagen elements but in parallel with elastin elements. 49 Hence, in the relaxed state, the effects of stretch are transferred to the more distensible elastin elements; supplemental dietary K + may enhance compliance through a similar mechanism.
Antihypertensive agents that act through mechanisms other than vasorelaxation need not enhance vascular compliance; for instance, diuretic therapy did not reduce aortic stiffness in either a genetic or an experimental rat model of hypertension, despite lowering blood pressure. 50 In our study, the extent to which supplemental K + enhances compliance bears no relation to the measured value of blood pressure. Thus, the observed capacity of K + to preserve arterial compliance cannot be judged to be a nonspecific effect of attenuation of hypertension. Furthermore, it is possible that the effect of supplemental dietary K + on arterial compliance could be a chronic/structural effect, which might account for a lack of correlation of compliance with blood pressure that is measured at a single point in time. Such a chronic/structural effect could be distinct from a preserving effect of K + on endothelial function, which could represent a more dynamic interaction between blood pressure and the vascular endothelium and its release of EDRF.
Supplemental K + can increase urinary sodium excretion in humans with and without hypertension 5154 and in animals. 55 - 56 Louis et al 57 reported that supplemental K + induced a reduction in exchangeable sodium in spontaneously hypertensive rats. However, Dietz 58 and Volpe et al 14 concluded that the antihypertensive effect of supplemental K + could not be related to a reduction in intravascular volume. Avolio et al 59 reported that in normotensive subjects dietary salt restriction was attended by a lesser vascular stiffness, as judged from a lower pulse wave velocity. The sodium content of the arterial wall has been reported to be increased in experimental hypertension 60 ; supplemental dietary K + might decrease vascular stiffness by inducing a decrease in vascular sodium. Although it is possible that a transient natriuresis occurred during the first few days of dietary K + supplementation in our study, we could not detect either natriuresis or a reduction in body weight (with KHCO 3 ) over the 3-week period of supplementation. Thus, neither a reduction in plasma volume nor tissue sodium can be readily invoked as a mechanism of either the attenuation of hypertension or enhancement of arterial compliance. It therefore remains to be investigated how transient nocturnal increases in plasma K + as observed in the current study might effect the attenuation of hypertension observed during the day and presumably extant throughout the 24-hour period. In the present study, the increase in urinary K + excretion induced by supplemental K + was greater with KHCO3 than with KG, as was the increase in nocturnal plasma K + , consistent with a greater intestinal absorption of K + as the bicarbonate salt.
Because the chloride ion has been shown to be important to the hypertensinogenic effect of sodium chloride in salt-sensitive rats, 61 -62 this anion might constrain the antihypertensive effect of supplemental potassium in the DS rat. However, in the short duration of the present study, the antihypertensive effect of supplemental potassium appeared to be similar in magnitude with either the chloride or bicarbonate salt. It is possible that with longer periods of potassium supplementation, lesser degrees of salt loading, or nocturnal measurements of blood pressure, dissimilar antihypertensive effects might be seen with different potassium salts.
In summary, we have shown that in salt-loaded DS rats, the extent to which supplemental dietary K + preserves endothelium-dependent relaxation varies directly with the extent to which supplemental K + restricts the rise in blood pressure, ie, inversely with directly measured arterial blood pressure. Furthermore, the antihypertensive effect of dietary K + is associated with an increase in nocturnal but not diurnal plasma K + . In addition, dietary K + supplementation enhances aortic compliance, an effect that may contribute to its antihypertensive effect.
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